Clarity with
Crown

Recognize your next clinical candidate when you see it.

Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.

SYMPOSIUM: Translational Oncology
Drug Discovery - From Target to Patient

22nd February 2017 - Babraham Research Campus, Cambridge, UK

Crown Bioscience invites you to attend a symposium focusing on the latest advances in Translational Oncology Drug Discovery.

Magnify your
insights

Understand the mechanisms of disease.

Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.

Begin with the
end insight

Connecting science to patients.

We help our clients solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease by answering some of the most challenging questions about human biology.

CVMD

Models of Obesity

obesity-img.jpg

CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.

Learn More

Oncology

Oncology Databases

databases-img.jpg

Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.

Learn More

CVMD

Diabetes Models

oncoexpress-img.jpg

Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.

Learn More

Latest from our Blog

December 13, 2016

Targeting Cardio-Metabolic Disease Symposium

Highlights from the NASH symposium and panel discussion in Boston, MA (Sep 20-21, 2016) Amar Thyagarajan, PhD

Read More

December 13, 2016

Targeting Cardio-Metabolic Disease Symposium

Highlights from the NASH symposium and panel discussion in Boston, MA (Sep 20-21, 2016) Amar...

Read More

October 6, 2016

Breast Cancer No Longer Scary as we Reveal Its Smarter Disguises

October is breast cancer awareness month and CrownBio has reviewed the latest breast cancer...

Read More

September 27, 2016

All You Need to Know About Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty liver disease (NAFLD) is a complex condition where an excessive amount of...

Read More

September 13, 2016

Obesity Linked To Self-Eating Beige Fat

Humans, like all mammals, have two types of fat with completely opposite functions: white, which...

Read More

September 6, 2016

All About Leukemia for Childhood Cancer Month

September is Childhood Cancer Awareness Month, raising awareness and providing time for...

Read More

Upcoming Events


Jan 24-25, 2017

Tumor Models - Increasing the Value of Preclinical & Translational Research for Cancer Immunotherapies

San Francisco, CA

Learn More


Jan 27-30, 2017

ECCO

Amsterdam, Netherlands

Learn More


Feb 1-3, 2017

Immuno-Oncology 360

New York, NY

Learn More


Feb 2-4, 2017

ENBL - Cancer Core Europe Conference: Cancer Immunotherapy

Heidelberg, Germany

Learn More


February 22, 2017

SYMPOSIUM: Translational Oncology Drug Discovery - From Target to Patient

Babraham Research Campus, Cambridge, UK

Learn More


Feb 20-22, 2017

World ADC

Berlin, Germany

Learn More


Feb 22-24, 2017

Enmore Bio Conference

Nanjing, China

Learn More


Feb 27-28, 2017

Frontiers in Cancer Immunotherapy

New York, NY

Learn More